159 related articles for article (PubMed ID: 31543462)
1. Discovery and Development of TMPRSS6 Inhibitors Modulating Hepcidin Levels in Human Hepatocytes.
Béliveau F; Tarkar A; Dion SP; Désilets A; Ghinet MG; Boudreault PL; St-Georges C; Marsault É; Paone D; Collins J; Macphee CH; Campobasso N; Groy A; Cottom J; Ouellette M; Pope AJ; Leduc R
Cell Chem Biol; 2019 Nov; 26(11):1559-1572.e9. PubMed ID: 31543462
[TBL] [Abstract][Full Text] [Related]
2. Essential role of endocytosis of the type II transmembrane serine protease TMPRSS6 in regulating its functionality.
Béliveau F; Brulé C; Désilets A; Zimmerman B; Laporte SA; Lavoie CL; Leduc R
J Biol Chem; 2011 Aug; 286(33):29035-29043. PubMed ID: 21724843
[TBL] [Abstract][Full Text] [Related]
3. Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.
Wahedi M; Wortham AM; Kleven MD; Zhao N; Jue S; Enns CA; Zhang AS
J Biol Chem; 2017 Nov; 292(44):18354-18371. PubMed ID: 28924039
[TBL] [Abstract][Full Text] [Related]
4. Retinal expression of the serine protease matriptase-2 (Tmprss6) and its role in retinal iron homeostasis.
Gnana-Prakasam JP; Baldowski RB; Ananth S; Martin PM; Smith SB; Ganapathy V
Mol Vis; 2014; 20():561-74. PubMed ID: 24791141
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.
Finberg KE; Whittlesey RL; Fleming MD; Andrews NC
Blood; 2010 May; 115(18):3817-26. PubMed ID: 20200349
[TBL] [Abstract][Full Text] [Related]
6. Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis.
Lakhal S; Schödel J; Townsend AR; Pugh CW; Ratcliffe PJ; Mole DR
J Biol Chem; 2011 Feb; 286(6):4090-7. PubMed ID: 20966077
[TBL] [Abstract][Full Text] [Related]
7. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.
Silvestri L; Pagani A; Nai A; De Domenico I; Kaplan J; Camaschella C
Cell Metab; 2008 Dec; 8(6):502-11. PubMed ID: 18976966
[TBL] [Abstract][Full Text] [Related]
8. Identification of TMPRSS6 cleavage sites of hemojuvelin.
Rausa M; Ghitti M; Pagani A; Nai A; Campanella A; Musco G; Camaschella C; Silvestri L
J Cell Mol Med; 2015 Apr; 19(4):879-88. PubMed ID: 25704252
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6.
Truksa J; Gelbart T; Peng H; Beutler E; Beutler B; Lee P
Br J Haematol; 2009 Nov; 147(4):571-81. PubMed ID: 19751239
[TBL] [Abstract][Full Text] [Related]
10. Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?
Rausa M; Pagani A; Nai A; Campanella A; Gilberti ME; Apostoli P; Camaschella C; Silvestri L
PLoS One; 2015; 10(4):e0122696. PubMed ID: 25860887
[TBL] [Abstract][Full Text] [Related]
11. Low intracellular iron increases the stability of matriptase-2.
Zhao N; Nizzi CP; Anderson SA; Wang J; Ueno A; Tsukamoto H; Eisenstein RS; Enns CA; Zhang AS
J Biol Chem; 2015 Feb; 290(7):4432-46. PubMed ID: 25550162
[TBL] [Abstract][Full Text] [Related]
12. Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in
Krijt J; Frýdlová J; Gurieva I; Přikryl P; Báječný M; Steinbicker AU; Vokurka M; Truksa J
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800732
[TBL] [Abstract][Full Text] [Related]
13. Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease.
Schaefer B; Haschka D; Finkenstedt A; Petersen BS; Theurl I; Henninger B; Janecke AR; Wang CY; Lin HY; Veits L; Vogel W; Weiss G; Franke A; Zoller H
Hum Mol Genet; 2015 Nov; 24(21):6254-63. PubMed ID: 26310624
[TBL] [Abstract][Full Text] [Related]
14. A functional interplay between the two BMP-SMAD pathway inhibitors TMPRSS6 and FKBP12 regulates
Pettinato M; Aghajan M; Guo S; Bavuso Volpe L; Carleo R; Nai A; Pagani A; Altamura S; Silvestri L
Am J Physiol Gastrointest Liver Physiol; 2024 Mar; 326(3):G310-G317. PubMed ID: 38252872
[TBL] [Abstract][Full Text] [Related]
15. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka VC; Janetka JW
Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
[TBL] [Abstract][Full Text] [Related]
16. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6.
Lenoir A; Deschemin JC; Kautz L; Ramsay AJ; Roth MP; Lopez-Otin C; Vaulont S; Nicolas G
Blood; 2011 Jan; 117(2):647-50. PubMed ID: 20940420
[TBL] [Abstract][Full Text] [Related]
17. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of matriptase-2 mutations and domains: insights into the molecular basis of iron-refractory iron deficiency anemia.
McDonald CJ; Ostini L; Bennett N; Subramaniam N; Hooper J; Velasco G; Wallace DF; Subramaniam VN
Am J Physiol Cell Physiol; 2015 Apr; 308(7):C539-47. PubMed ID: 25588876
[TBL] [Abstract][Full Text] [Related]
19. Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin.
Krijt J; Fujikura Y; Sefc L; Vokurka M; Hlobenová T; Necas E
Physiol Res; 2010; 59(1):53-59. PubMed ID: 19249912
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte neogenin is required for hemojuvelin-mediated hepcidin expression and iron homeostasis in mice.
Enns CA; Jue S; Zhang AS
Blood; 2021 Aug; 138(6):486-499. PubMed ID: 33824974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
